Congrats to @DOM_UCLA #zoeedcosta in reporting this difficult #cardioonc structural case in attempting to alleviate severe hypoxemia from HPS from malignant neuroendocrine transformation of prostate CA w/ PFO closure Multidisciplinary teamwork is critical! https://t.co/GiwDKjcm3f

We are thrilled to receive NOA of our 2nd @NIH NHLBI R01. We propose a strategy to target ICI myocarditis & preserve critical tumor killing by ICI. Grateful to our lab members & collaborators. @StanfordCVI #CardioOnc We are recruiting new postdocs👉 https://t.co/5xLzTgQfBe

A 🔥 @AtriumHealth @advocatehealth #cardioonc symposium led by @JaiSingh_MD @amar_parikh! A 🤯 feat of balancing #cardioonc, cancer, & ♥️ disease in a forum that engages EVERYONE in cardiology, not just our tribe. Excited to see this 🚀 🙏 for letting us be a part of this!!

🔴 Prevention of cancer therapy-related cardiac dysfunction & heart failure in cancer patients & survivors. A Clinical Consensus Statement @ESC_Journals #Cardioed #Cardiology #CardioOnc

🎉Congratulations to a great friend and collaborator to the Thalheimer Center, Dr. Jennifer Wei Zou, for being elected President Elect of the Delaware Valley Chapter of the American Association of Physicists in Medicine!! #RadOnc #CardioOnc

Clonal Hematopoiesis increases Cardiotoxic #AF risk following Allo-stem cell transplant: https://t.co/vSlHjBXZ6b Thanks @JAHA_AHA for publishing. Nice work by @CooperQuar @AdnanShaabanMD @AlmaHabibMD and many others. #CHIP #cardioonc #cancer #leukemia

Honored to be the opening speaker for the annual #Egyptian Cardio-oncology conference in Cairo. The international talent in the field is humbling and the investment in #CardioOnc research is groundbreaking for patients all over the world. @icosociety #UTSW

Full house at the Judy DiMarzo Survivorship Symposium in Rochester New York ⁦⁦@WilmotCancer⁩

Congratulations to Dr. Akito Shindo @shinakito for being a finalist for the young investigator award at #ESCCongress2025! @shinakito will be joining us at @UCSFCardiology as #CardioOnc Fellow in 2026! https://t.co/SiYZV5EhyH

Great to meet such a great cardio-onc group during the regional Cardio-onc symposium on current paradigms in CV care of cancer patients and survivors #cardiotwitter #CardioOnc

We’re close to @AHAScience #AHA25. Excited to present our work on the CV implications of PH and hemodynamic phenotypes in patients with #MPNsm. Looking forward to catching up with old friends and network with new ones! #cardioonc #hemodynamics @GabyHobbs @datsunian

Great evening of engaging talks by Drs.@SKabrajiMD @sdent_cardioonc @JoshDragoMD @JuliaFoldiMD thoughtful discussions on therapy selection and sequencing in breast cancer. ✨✨ @OncLive

How to prevent heart failure AND cancer? #HFSA2025 Super session on multidisciplinary approach! You will need your oncologist, pharmacist + #CardioOnc #HFSAScientificStatement Dr Alana Ferrari @drmishbloom @DhariniRamu @BlaesAnneMD @anita_deswal

Join Dr Dan Lenihan and Dr Joe Carver TODAY at 14:00 BST | 09:00 EDT as they discuss complex #CardioOnc cases 👉 https://t.co/CUMoVL0FWw ✅ Learn practical strategies from real patient scenarios ✅ Gain expert insights to guide complex clinical decisions Last chance to

🔴 Beyond Thrombosis: Pulmonary Hypertension & Heart Failure in Patients With Myeloproliferative Neoplasms: State-of-the-Art Review @JACCJournals #Cardiology #CardioEd #CardioOnc #FOAMed @LeivaOrly @Anand_88_Patel @GabyHobbs

Biomarker-based Dx model proves effective in ruling out LV dysfunction, offering potential to minimize unnecessary surveillance echo in childhood cancer survivors. External validation is essential to confirm these findings. https://t.co/sEt8XeBUko #JACCCardioOnc #CardioOnc #cvPed

If you cannot make it in person to stunning Cape Town South Africa for the premiere #cardioonc #GCOS2025 you can now still participate via our virtual option. Registration is now available. Sign up today!

#JACCCardioOnc review provides an in-depth analysis of the evidence linking clonal hematopoiesis with solid organ malignancies and explores its role as a shared risk factor for the development of both #CVD and cancer. https://t.co/eG3ziPQqX3 #CardioOnc

🧬 New insights from iPSC models reveal how heart disease and cancer share genetic and metabolic pathways. A promising step toward personalized therapies in cardio-oncology. #CardioOnc #iPSCs @StanfordCVI @CardioOncology 📰 https://t.co/I0Y9jT6tAc